Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Pharmacogenomics|April 1, 2011
Risk modeling strategies for pharmacogenetic studiesAndrea L Jorgensen, Munir PirmohamedStatistics in Medicine|October 7, 2008
Methodological quality of pharmacogenetic studies: issues of concernAndrea L Jorgensen, Paula R WilliamsonJournal of Personalized Medicine|January 27, 2017
Biomarker-Guided Non-Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewMiranta Antoniou, Ruwanthi Kolamunnage-Dona, Andrea L JorgensenBMC Bioinformatics|May 21, 2017
SurvivalGWAS_SV: software for the analysis of genome-wide association studies of imputed genotypes with "time-to-event" outcomesHamzah Syed, Andrea L Jorgensen, Andrew P MorrisPharmacogenomics|June 2, 2016
Evaluation of methodology for the analysis of 'time-to-event' data in pharmacogenomic genome-wide association studiesHamzah Syed, Andrea L Jorgensen, Andrew P MorrisJournal of Personalized Medicine|December 7, 2017
Fixed and Adaptive Parallel Subgroup-Specific Design for Survival Outcomes: Power and Sample SizeMiranta Antoniou, Andrea L Jorgensen, Ruwanthi Kolamunnage-DonaBMC Bioinformatics|December 10, 2016
SurvivalGWAS_Power: a user friendly tool for power calculations in pharmacogenetic studies with "time to event" outcomesHamzah Syed, Andrea L Jorgensen, Andrew P MorrisPlos One|February 25, 2016
Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewMiranta Antoniou, Andrea L Jorgensen, Ruwanthi Kolamunnage-DonaClinical and Translational Science|August 5, 2025
APOE Genotype and Statin Response: Evidence From the UK Biobank and All of Us ProgramInnocent G Asiimwe, Andrea L Jorgensen, Munir Pirmohamed, et al.The Cochrane Database of Systematic Reviews|April 20, 2012
Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancyZarko Alfirevic, Tamara Stampalija, Devender Roberts, et al.Pageof 8